Bluejay Diagnostics Statistics
Share Statistics
Bluejay Diagnostics has 552.85K shares outstanding. The number of shares has increased by 831.29% in one year.
| Shares Outstanding | 552.85K |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2834.27% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 551.23K |
| Failed to Deliver (FTD) Shares | 288.49K |
| FTD / Avg. Volume | 45.7% |
Short Selling Information
The latest short interest is 159.88K, so 29.74% of the outstanding shares have been sold short.
| Short Interest | 159.88K |
| Short % of Shares Out | 29.74% |
| Short % of Float | 29.74% |
| Short Ratio (days to cover) | 0.09 |
Valuation Ratios
The PE ratio is -6.72 and the forward PE ratio is -0.34.
| PE Ratio | -6.72 |
| Forward PE | -0.34 |
| PS Ratio | 0 |
| Forward PS | 0.5 |
| PB Ratio | 23.11 |
| P/FCF Ratio | -7.42 |
| PEG Ratio | n/a |
Enterprise Valuation
Bluejay Diagnostics Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.
| Current Ratio | 1.82 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -3.44% and return on capital (ROIC) is -317.48%.
| Return on Equity (ROE) | -3.44% |
| Return on Assets (ROA) | -2.04% |
| Return on Capital (ROIC) | -317.48% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -995.39K |
| Employee Count | 10 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.59% in the last 52 weeks. The beta is 0.73, so Bluejay Diagnostics 's price volatility has been higher than the market average.
| Beta | 0.73 |
| 52-Week Price Change | -99.59% |
| 50-Day Moving Average | 4.74 |
| 200-Day Moving Average | 107.92 |
| Relative Strength Index (RSI) | 51.27 |
| Average Volume (20 Days) | 631.21K |
Income Statement
In the last 12 months, Bluejay Diagnostics had revenue of $0 and earned -$9.95M in profits. Earnings per share was $-72.62.
| Revenue | 0 |
| Gross Profit | -780.96K |
| Operating Income | -10.31M |
| Net Income | -9.95M |
| EBITDA | -9.17M |
| EBIT | - |
| Earnings Per Share (EPS) | -72.62 |
Balance Sheet
The company has $2.21M in cash and $352.98K in debt, giving a net cash position of $1.86M.
| Cash & Cash Equivalents | 2.21M |
| Total Debt | 352.98K |
| Net Cash | 1.86M |
| Retained Earnings | -26.95M |
| Total Assets | 8.35M |
| Working Capital | 5.52M |
Cash Flow
In the last 12 months, operating cash flow was -$8.31M and capital expenditures -$704.17K, giving a free cash flow of -$9.02M.
| Operating Cash Flow | -8.31M |
| Capital Expenditures | -704.17K |
| Free Cash Flow | -9.02M |
| FCF Per Share | -65.8 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
BJDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1538.56% |
| FCF Yield | -345.59% |
Analyst Forecast
Currently there are no analyst rating for BJDX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 18, 2024. It was a backward split with a ratio of 1:50.
| Last Split Date | Nov 18, 2024 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -6.6 |
| Piotroski F-Score | 2 |